{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:03:55Z","timestamp":1793070235910,"version":"4.5.0"},"reference-count":95,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","mayoclinicproceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.mayocp.2022.03.039","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T06:06:49Z","timestamp":1662012409000},"page":"1734-1751","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement"],"prefix":"10.1016","volume":"97","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2145-4995","authenticated-orcid":false,"given":"Sunil K.","family":"Sahai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7264-6682","authenticated-orcid":false,"given":"Konstantin","family":"Balonov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2908-4477","authenticated-orcid":false,"given":"Nathalie","family":"Bentov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3337-5645","authenticated-orcid":false,"given":"Dennis M. (Mike)","family":"Bierle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0726-7755","authenticated-orcid":false,"given":"Lorinda M.","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6166-8352","authenticated-orcid":false,"suffix":"III","given":"Kenneth C.","family":"Cummings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M.","family":"Dougan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geno J.","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3369-382X","authenticated-orcid":false,"given":"Adriana D.","family":"Oprea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BobbieJean","family":"Sweitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2956-2774","authenticated-orcid":false,"given":"Karen F.","family":"Mauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0516-5977","authenticated-orcid":false,"given":"Richard D.","family":"Urman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mayocp.2022.03.039_bib1","series-title":"WHO\u2019s Global Health Estimates: The Top 10 Causes of Death","year":"2020"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib2","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1213\/ANE.0000000000002837","article-title":"A\u00a0systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery","volume":"127","author":"Hollmann","year":"2018","journal-title":"Anesth Analg"},{"key":"10.1016\/j.mayocp.2022.03.039_bib3","series-title":"UpToDate","article-title":"Perioperative medication management","author":"Muluk","year":"2020"},{"issue":"19","key":"10.1016\/j.mayocp.2022.03.039_bib4","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"10","key":"10.1016\/j.mayocp.2022.03.039_bib5","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/EJA.0000000000000150","volume":"31","author":"Kristensen","year":"2014","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib6","first-page":"17","article-title":"Canadian Cardiovascular Society Guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery","volume":"33","author":"Duceppe","year":"2017","journal-title":"Can J Cardiol"},{"issue":"24","key":"10.1016\/j.mayocp.2022.03.039_bib7","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1161\/CIR.0000000000000105","article-title":"2014 ACC\/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Fleisher","year":"2014","journal-title":"Circulation"},{"issue":"33","key":"10.1016\/j.mayocp.2022.03.039_bib8","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016872","article-title":"Angiotensin axis blockade, acute kidney injury, and perioperative morbidity in patients undergoing colorectal surgery: a retrospective cohort study","volume":"98","author":"Bonavia","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib9","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jhm.2155","article-title":"Angiotensin axis blockade, hypotension, and acute kidney injury in elective major orthopedic surgery","volume":"9","author":"Nielson","year":"2014","journal-title":"J\u00a0Hosp Med"},{"issue":"9","key":"10.1016\/j.mayocp.2022.03.039_bib10","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/imj.13487","article-title":"Association of renin angiotensin antagonists with adverse perioperative events in patients undergoing elective orthopaedic surgery: a case-control study","volume":"47","author":"Zainudheen","year":"2017","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib11","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1067\/mhj.2001.111547","article-title":"Perioperative beta-blocker withdrawal and mortality in vascular surgical patients","volume":"141","author":"Shammash","year":"2001","journal-title":"Am Heart J"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib12","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.mayocp.2020.06.022","article-title":"Striving for evidence-based, patient-centered guidance: the impetus behind the Society for Perioperative Assessment and Quality Improvement (SPAQI) Medication Management Consensus Statements","volume":"96","author":"O\u2019Glasser","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.mayocp.2022.03.039_bib13","author":"Klabunde"},{"issue":"2 suppl","key":"10.1016\/j.mayocp.2022.03.039_bib14","first-page":"S1","article-title":"Clinical consensus statement development manual","volume":"153","author":"Rosenfeld","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"12","key":"10.1016\/j.mayocp.2022.03.039_bib15","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.mayocp.2021.08.008","article-title":"Preoperative management of gastrointestinal and pulmonary medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib16","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.mayocp.2020.10.002","article-title":"Preoperative management of endocrine, hormonal, and urologic medications: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement","volume":"96","author":"Pfeifer","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib17","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/j.mayocp.2020.06.045","article-title":"Preoperative management of opioid and nonopioid analgesics: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement","volume":"96","author":"O\u2019Rourke","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib18","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/j.mayocp.2020.08.016","article-title":"Preoperative management of surgical patients using dietary supplements: Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement","volume":"96","author":"Cummings","year":"2021","journal-title":"Mayo Clin Proc"},{"issue":"22","key":"10.1016\/j.mayocp.2022.03.039_bib20","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.21037\/atm-20-3214","article-title":"A\u00a0narrative review of intraoperative floppy iris syndrome: an update 2020","volume":"8","author":"Yang","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.mayocp.2022.03.039_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.phrs.2017.07.026","article-title":"Antihypertensive drugs","volume":"124","author":"Laurent","year":"2017","journal-title":"Pharmacol Res"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib22","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1136\/heartjnl-2018-313492","article-title":"Fixed-dose combination antihypertensives and risk of medication errors","volume":"105","author":"Moriarty","year":"2019","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib23","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/bja\/83.5.715","article-title":"Effect of omitting regular ACE inhibitor medication before cardiac surgery on haemodynamic variables and vasoactive drug requirements","volume":"83","author":"Pigott","year":"1999","journal-title":"Br J Anaesth"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib24","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00000542-199408000-00006","article-title":"Influence of chronic angiotensin-converting enzyme inhibition on anesthetic induction","volume":"81","author":"Coriat","year":"1994","journal-title":"Anesthesiology"},{"issue":"10","key":"10.1016\/j.mayocp.2022.03.039_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.12788\/jhm.3036","article-title":"Prospective randomized evaluation of preoperative angiotensin-converting enzyme inhibition (PREOP-ACEI)","volume":"13","author":"Shiffermiller","year":"2018","journal-title":"J\u00a0Hosp Med"},{"issue":"4","key":"10.1016\/j.mayocp.2022.03.039_bib26","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/jhm.323","article-title":"Clinical consequences of withholding versus administering renin-angiotensin-aldosterone system antagonists in the preoperative period","volume":"3","author":"Rosenman","year":"2008","journal-title":"J\u00a0Hosp Med"},{"key":"10.1016\/j.mayocp.2022.03.039_bib27","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.5061","article-title":"Perioperative management of angiotensin-converting enzyme inhibitors and\/or angiotensin receptor blockers: a survey of perioperative medicine practitioners","volume":"6","author":"Walker","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/j.mayocp.2022.03.039_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jclinane.2017.04.018","article-title":"Perioperative use of angiotensin-converting-enzyme inhibitors and angiotensin receptor antagonists","volume":"40","author":"Vaquero Roncero","year":"2017","journal-title":"J\u00a0Clin Anesth"},{"key":"10.1016\/j.mayocp.2022.03.039_bib29","first-page":"CD009210","article-title":"Perioperative angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers for preventing mortality and morbidity in adults","volume":"2016","author":"Zou","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s12350-014-0025-z","volume":"22","author":"Fleisher","year":"2015","journal-title":"J\u00a0Nucl Cardiol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib31","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1213\/ANE.0b013e318241f6af","article-title":"Angiotensin converting enzyme inhibitors are not associated with respiratory complications or mortality after noncardiac surgery","volume":"114","author":"Turan","year":"2012","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib32","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/ALN.0000000000001404","article-title":"Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the Vascular events In noncardiac Surgery patIents cOhort evaluatioN prospective cohort","volume":"126","author":"Roshanov","year":"2017","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib33","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1053\/j.jvca.2020.01.005","article-title":"Continuation of angiotensin-converting enzyme inhibitors on the day of surgery is not associated with increased risk of hypotension upon induction of general anesthesia in elective noncardiac surgeries","volume":"35","author":"Yoon","year":"2021","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib34","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.bja.2019.01.018","volume":"122","author":"Sanders","year":"2019","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s13063-019-3247-1","article-title":"STOP-OR-NOT study investigators. Impact of renin-angiotensin system inhibitors continuation versus discontinuation on outcome after major surgery: protocol of a multicenter randomized, controlled trial (STOP-or-NOT trial)","volume":"20","author":"Legrand","year":"2019","journal-title":"Trials"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/jhm.2182","article-title":"Thirty-day mortality risk associated with the postoperative nonresumption of angiotensin-converting enzyme inhibitors: a retrospective study of the Veterans Affairs Healthcare System","volume":"9","author":"Mudumbai","year":"2014","journal-title":"J\u00a0Hosp Med"},{"issue":"17","key":"10.1016\/j.mayocp.2022.03.039_bib37","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2014-306775","article-title":"The neprilysin pathway in heart failure: a review and guide on the use of sacubitril\/valsartan","volume":"102","author":"Jhund","year":"2016","journal-title":"Heart"},{"issue":"supplement","key":"10.1016\/j.mayocp.2022.03.039_bib38","first-page":"S49","article-title":"Pharmacological update: new drugs in cardiac practice: a critical appraisal","volume":"20","author":"Magoon","year":"2017","journal-title":"Ann Card Anaesth"},{"issue":"4","key":"10.1016\/j.mayocp.2022.03.039_bib39","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/ALN.0b013e3181f1c061","article-title":"Association of the pattern of use of perioperative \u03b2-blockade and postoperative mortality","volume":"113","author":"Wallace","year":"2010","journal-title":"Anesthesiology"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib40","first-page":"115","article-title":"Contemporary personalized \u03b2-blocker management in the perioperative setting","volume":"34","author":"Oprea","year":"2020","journal-title":"J\u00a0Anesth"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1097\/ACO.0000000000000853","article-title":"Perioperative \u03b2-blocker use: what is new in 2020?","volume":"33","author":"Wang","year":"2020","journal-title":"Curr Opin Anaesthesiol"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib42","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0003-4975(10)61133-2","article-title":"Rebound vasospasm after coronary revascularization in association with calcium antagonist withdrawal","volume":"37","author":"Engelman","year":"1984","journal-title":"Ann Thorac Surg"},{"issue":"4","key":"10.1016\/j.mayocp.2022.03.039_bib43","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/1053-0770(92)90007-T","article-title":"Hemodynamic effect of calcium channel blockade during anesthesia for coronary artery surgery","volume":"6","author":"Colson","year":"1992","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib44","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0022-5223(03)00695-0","article-title":"Calcium antagonists are associated with reduced mortality after cardiac surgery: a propensity analysis","volume":"127","author":"Wijeysundera","year":"2004","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1213\/01.ANE.0000081732.51871.D2","article-title":"Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis","volume":"97","author":"Wijeysundera","year":"2003","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/00007691-199212000-00009","article-title":"Pharmacokinetics of diltiazem in patients undergoing coronary artery bypass grafting","volume":"14","author":"Finegan","year":"1992","journal-title":"Ther Drug Monit"},{"issue":"4","key":"10.1016\/j.mayocp.2022.03.039_bib47","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1161\/01.STR.27.4.593","article-title":"Nimodipine neuroprotection in cardiac valve replacement: report of an early terminated trial","volume":"27","author":"Legault","year":"1996","journal-title":"Stroke"},{"issue":"6982","key":"10.1016\/j.mayocp.2022.03.039_bib48","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1136\/bmj.310.6982.776","article-title":"Surgical bleeding: unexpected effect of a calcium antagonist","volume":"310","author":"Wagenknecht","year":"1995","journal-title":"BMJ"},{"issue":"7081","key":"10.1016\/j.mayocp.2022.03.039_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1136\/bmj.314.7081.643","article-title":"Use of calcium antagonists and need for perioperative transfusion in older patients with hip fracture: observational study","volume":"314","author":"Zuccal\u00e1","year":"1997","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib50","first-page":"105","article-title":"Effects of calcium antagonists on the risks of coronary heart disease, cancer and bleeding","volume":"15","year":"1997","journal-title":"J\u00a0Hypertens"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/14740330903499240","article-title":"Diuretics in clinical practice. Part I: mechanisms of action, pharmacological effects and clinical indications of diuretic compounds","volume":"9","author":"Sarafidis","year":"2010","journal-title":"Expert Opin Drug Saf"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib52","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1586\/erc.10.27","article-title":"Mechanisms for blood pressure lowering and metabolic effects of thiazide and thiazide-like diuretics","volume":"8","author":"Duarte","year":"2010","journal-title":"Expert Rev Cardiovasc Ther"},{"issue":"4","key":"10.1016\/j.mayocp.2022.03.039_bib53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/00007611-199804000-00009","article-title":"Chronic medications in the perioperative period","volume":"91","author":"Kroenke","year":"1998","journal-title":"South Med J"},{"issue":"11","key":"10.1016\/j.mayocp.2022.03.039_bib54","doi-asserted-by":"crossref","first-page":"1059.e1051","DOI":"10.1016\/j.amjmed.2010.07.019","article-title":"Risk of intraoperative hypotension with loop diuretics: a randomized controlled trial","volume":"123","author":"Khan","year":"2010","journal-title":"Am J Med"},{"issue":"23","key":"10.1016\/j.mayocp.2022.03.039_bib55","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1001\/jama.281.23.2203","article-title":"Multicenter Study of Perioperative Ischemia Research Group. Preoperative serum potassium levels and perioperative outcomes in cardiac surgery patients","volume":"281","author":"Wahr","year":"1999","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1213\/00000539-198802000-00005","article-title":"The overstated risk of preoperative hypokalemia","volume":"67","author":"Hirsch","year":"1988","journal-title":"Anesth Analg"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib57","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1053\/j.ajkd.2015.07.022","article-title":"Acute kidney injury after major surgery: a retrospective analysis of Veterans Health Administration Data","volume":"67","author":"Grams","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib58","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1053\/j.ajkd.2016.06.013","article-title":"The effect of spironolactone on acute kidney injury after cardiac surgery: a randomized, placebo-controlled trial","volume":"69","author":"Barba-Navarro","year":"2017","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib59","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1124\/pr.115.011833","article-title":"Endothelin","volume":"68","author":"Davenport","year":"2016","journal-title":"Pharmacol Rev"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib60","first-page":"824","article-title":"Endothelin receptor antagonists: status quo and future perspectives for targeted therapy","volume":"9","author":"Enevoldsen","year":"2020","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.mayocp.2022.03.039_bib61","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2147\/VHRM.S133921","article-title":"Endothelin-receptor antagonists in the management of pulmonary arterial hypertension: where do we stand?","volume":"14","author":"Correale","year":"2018","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.mayocp.2022.03.039_bib62","series-title":"Package insert","author":"Tracleer","year":"2017"},{"key":"10.1016\/j.mayocp.2022.03.039_bib63","series-title":"Package insert","author":"Letairis","year":"2019"},{"issue":"12","key":"10.1016\/j.mayocp.2022.03.039_bib64","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa012212","article-title":"Bosentan therapy for pulmonary arterial hypertension","volume":"346","author":"Rubin","year":"2002","journal-title":"N\u00a0Engl J Med"},{"issue":"7\u20138","key":"10.1016\/j.mayocp.2022.03.039_bib65","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1345\/aph.1C398","article-title":"Bosentan and warfarin interaction","volume":"37","author":"Murphey","year":"2003","journal-title":"Ann Pharmacother"},{"issue":"4","key":"10.1016\/j.mayocp.2022.03.039_bib66","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.rmed.2010.12.006","article-title":"Pulmonary hypertension: an important predictor of outcomes in patients undergoing non-cardiac surgery","volume":"105","author":"Kaw","year":"2011","journal-title":"Respir Med"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib67","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s40256-018-0292-1","article-title":"Clinical use of digitalis: a state of the art review","volume":"18","author":"Whayne","year":"2018","journal-title":"Am J Cardiovasc. Drugs"},{"issue":"5 pt 1","key":"10.1016\/j.mayocp.2022.03.039_bib68","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/0002-8703(82)90428-8","article-title":"Postoperative supraventricular arrhythmias and the role of prophylactic digoxin in cardiac surgery","volume":"104","author":"Chee","year":"1982","journal-title":"Am Heart J"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib69","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/bja\/86.3.332","article-title":"Dose-dependent prophylactic effect of nicorandil, an ATP-sensitive potassium channel opener, on intra-operative myocardial ischaemia in patients undergoing major abdominal surgery","volume":"86","author":"Kaneko","year":"2001","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.mayocp.2022.03.039_bib70","first-page":"CD010726","article-title":"Nitrates for the prevention of cardiac morbidity and mortality in patients undergoing non-cardiac surgery","volume":"8","author":"Zhao","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"34","key":"10.1016\/j.mayocp.2022.03.039_bib71","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016929","article-title":"Perioperative acute myocardial infarction in patients after non-cardiac surgery in China: characteristics and risk factors","volume":"98","author":"Zhou","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib72","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1016\/j.jtcvs.2006.08.035","article-title":"Effect of oral sildenafil citrate on intraoperative hemodynamics in patients with pulmonary hypertension undergoing valvular heart surgery","volume":"132","author":"Shim","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"issue":"eLetters Supplement","key":"10.1016\/j.mayocp.2022.03.039_bib73","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/el_2514","article-title":"Severe hypotension due to synergistic action of sildenafil with epidural analgesia","volume":"101","author":"Krovvidi","year":"2008","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib74","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1001\/archopht.123.3.400","article-title":"Recurrent visual field defect and ischemic optic neuropathy associated with tadalafil rechallenge","volume":"123","author":"Bollinger","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib75","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0161-6420(01)00976-9","article-title":"Sildenafil-associated nonarteritic anterior ischemic optic neuropathy","volume":"109","author":"Pomeranz","year":"2002","journal-title":"Ophthalmology"},{"issue":"7","key":"10.1016\/j.mayocp.2022.03.039_bib76","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.jclinane.2008.05.018","article-title":"Are guidelines needed for the perioperative discontinuation of phosphodiesterase type 5 inhibitors?","volume":"20","author":"McAllister","year":"2008","journal-title":"J\u00a0Clin Anesth"},{"issue":"7","key":"10.1016\/j.mayocp.2022.03.039_bib77","article-title":"Phosphodiesterase-5 (PDE5) inhibitors in the management of erectile dysfunction","volume":"38","author":"Huang","year":"2013","journal-title":"P\u00a0T"},{"issue":"17","key":"10.1016\/j.mayocp.2022.03.039_bib78","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1161\/CIRCULATIONAHA.118.035455","article-title":"Modernized classification of cardiac antiarrhythmic drugs","volume":"138","author":"Lei","year":"2018","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib79","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ccep.2016.02.009","article-title":"Proarrhythmic and torsadogenic effects of potassium channel blockers in patients","volume":"8","author":"McCauley","year":"2016","journal-title":"Card Electrophysiol Clin"},{"key":"10.1016\/j.mayocp.2022.03.039_bib80","series-title":"Perioperative Medicine","first-page":"23","article-title":"Perioperative medication management","author":"Cohn","year":"2011"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib81","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/1574884712666170829114820","article-title":"Perioperative management of beta blockers and other antiarrhythmic medications","volume":"12","author":"Irizarry-Alvarado","year":"2017","journal-title":"Curr Clin Pharmacol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib82","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1053\/j.jvca.2018.01.018","article-title":"Perioperative management of cardiovascular medications","volume":"32","author":"Lomivorotov","year":"2018","journal-title":"J\u00a0Cardiothorac Vasc Anesth"},{"issue":"1029","key":"10.1016\/j.mayocp.2022.03.039_bib83","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/pgmj.2010.112987","article-title":"Renin-angiotensin system antagonists in the perioperative setting: clinical consequences and recommendations for practice","volume":"87","author":"Auron","year":"2011","journal-title":"Postgrad Med J"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib84","first-page":"623","article-title":"Pharmacokinetics and pharmacodynamics of aliskiren, an oral direct renin inhibitor","volume":"60","author":"Buczko","year":"2008","journal-title":"Pharmacol Rep"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib85","article-title":"Ranolazine: a contemporary review","volume":"5","author":"Rayner-Hartley","year":"2016","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"18","key":"10.1016\/j.mayocp.2022.03.039_bib86","first-page":"e876","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mayocp.2022.03.039_bib87","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"8","key":"10.1016\/j.mayocp.2022.03.039_bib88","article-title":"Overview of sodium-glucose co-transporter 2 (SGLT2) inhibitors for the treatment of non-diabetic heart failure patients","volume":"13","author":"Balan","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"10.1016\/j.mayocp.2022.03.039_bib89","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.bja.2019.03.028","article-title":"Perioperative diabetic ketoacidosis associated with sodium-glucose co-transporter-2 inhibitors: a systematic review","volume":"123","author":"Thiruvenkatarajan","year":"2019","journal-title":"Br J Anaesth"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib90","article-title":"Euglycemic diabetic ketoacidosis and sodium-glucose cotransporter-2 inhibitors: a focused review of pathophysiology, risk factors, and triggers","volume":"13","author":"Somagutta","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/j.mayocp.2022.03.039_bib91","doi-asserted-by":"crossref","first-page":"690529","DOI":"10.3389\/fcvm.2021.690529","article-title":"Meta-analysis on the safety and cardiorenal efficacy of SGLT2 inhibitors in patients without T2DM","volume":"8","author":"Li","year":"2021","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.mayocp.2022.03.039_bib92","article-title":"Postoperative ketoacidosis with hypoglycemia in a nondiabetic patient taking dapagliflozin for heart failure: a case report","volume":"16","author":"Seki","year":"2022","journal-title":"A\u00a0A Pract"},{"key":"10.1016\/j.mayocp.2022.03.039_bib93","first-page":"374","article-title":"Continuing versus withholding angiotensin receptor blocker (ARB)\/calcium channel blocker (CCB) combination tablets during perioperative periods in patients undergoing minor surgery: a single-blinded randomized controlled trial","volume":"36","author":"Takeuchi","year":"2022","journal-title":"J\u00a0Anesth"},{"issue":"2","key":"10.1016\/j.mayocp.2022.03.039_bib94","first-page":"4","article-title":"Causes for postponement of cataract surgery in a peripheral eye hospital","volume":"5","author":"Bharti","year":"2018","journal-title":"Int J Health Educ Med Informatics"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib95","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1590\/S0004-27492012000500007","article-title":"[Cancellation of cataract surgery in a public hospital]","volume":"75","author":"Magri","year":"2012","journal-title":"Arq Bras Oftalmol"},{"issue":"5","key":"10.1016\/j.mayocp.2022.03.039_bib96","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/bja\/aex247","article-title":"Hypertension and cataract surgery under loco-regional anaesthesia: not to be ignored?","volume":"119","author":"Kumar","year":"2017","journal-title":"Br J Anaesth"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622002646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619622002646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:38:31Z","timestamp":1758418711000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619622002646"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0025619622002646"],"URL":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.03.039","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative Management of Cardiovascular Medications: A Society for Perioperative Assessment and Quality Improvement (SPAQI) Consensus Statement","name":"articletitle","label":"Article Title"},{"value":"Mayo Clinic Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mayocp.2022.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Mayo Foundation for Medical Education and Research","name":"copyright","label":"Copyright"}]}}